American Health Intel Rules. Money. Medicine. Decoded daily.
Subscribe
← All editions
Following a story · 3 updates

PROGRESS trial favors valve replacement in moderate aortic stenosis

Oct 27, 2026 – Nov 8, 2026

  1. Oct 27, 2026 The Service Line Record

    TCT 2026 trials that bear on coverage

    The Transcatheter Cardiovascular Therapeutics meeting runs October 31 to November 3 in San Diego with 28 late-breaking studies, including PROGRESS on TAVR in moderate aortic stenosis, and no results are public yet.

    Read this issue →
  2. Nov 1, 2026 The Service Line Record

    PROGRESS TAVR trial scheduled Monday

    The PROGRESS randomized trial of valve replacement versus clinical surveillance in moderate aortic stenosis is scheduled for primary results on Monday, November 2, with no results found yet.

    Read this issue →
  3. Nov 8, 2026 The Service Line Report Latest

    PROGRESS trial favors valve replacement in moderate aortic stenosis

    In 744 patients with moderate aortic stenosis and at-risk features, Edwards' Sapien 3 produced death or heart-failure events in 16.7 percent versus 23.9 percent with surveillance at two years, with similar all-cause mortality.

    Read this issue →